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Abstract 
The goal of radiation therapy is to achieve maximal therapeutic benefit expressed in terms of 
a high probability of local control of disease with minimal side effects. Physically this often 
equates to the delivery of a high dose of radiation to the tumour or target region whilst 
maintaining an acceptably low dose to other tissues, particularly those adjacent to the target. 
Techniques such as intensity modulated radiotherapy (IMRT), stereotactic radiosurgery and 
computer planned brachytherapy provide the means to calculate the radiation dose delivery to 
achieve the desired dose distribution. Imaging is an essential tool in all state of the art 
planning and delivery techniques: i) to enable planning of the desired treatment, ii) to verify 
the treatment is delivered as planned and iii) to follow up treatment outcome to monitor that 
the treatment has had the desired effect. Clinical imaging techniques can be loosely classified 
into anatomic methods which measure the basic physical characteristics of tissue such as their 
density and biological imaging techniques which measure functional characteristics such as 
metabolism. In this article we consider anatomical imaging techniques. Biological imaging is 
considered in an accompanying article. 
 
Anatomical imaging is generally used for goals i) and ii) above. Computed tomography (CT) 
has been the mainstay of anatomical treatment planning for many years, enabling some 
delineation of soft tissue as well as radiation attenuation estimation for dose prediction. 
Magnetic resonance is fast becoming widespread alongside CT, enabling superior soft tissue 
visualisation. Traditionally scanning for treatment planning has relied on the use of a single 
snapshot scan. Recent years have seen the development of techniques such as 4D CT and 
adaptive radiotherapy (ART). In 4D CT raw data is encoded with phase information and 
reconstructed to yield a set of scans detailing motion through the breathing, or cardiac, cycle. 
In ART a set of scans is taken on different days. Both allow planning to account for 
variability intrinsic to the patient. Treatment verification has been carried out using a variety 
of technologies including: MV portal imaging, kV portal/fluoroscopy, MVCT, conebeam 
kVCT, ultrasound and optical surface imaging. The various methods have their pros and cons. 
The four x-ray methods involve an extra radiation dose to normal tissue. The portal methods 
may not generally be used to visualise soft tissue, consequently they are often used in 
conjunction with implanted fiducial markers. The two CT based methods allow measurement 
of inter-fraction variation only. Ultrasound allows soft tissue measurement with zero dose but 
requires skilled interpretation and there is evidence of systematic differences between 
ultrasound and other data sources, perhaps due to the effects of the probe pressure. Optical 
imaging also involves zero dose, but requires good correlation between the target and the 
external measurement and thus is often used in conjunction with an x-ray method. 
 
The use of anatomical imaging in radiotherapy allows treatment uncertainties to be 
determined. These include errors between the mean position at treatment and that at planning 
(the systematic error) and the day to day variation in treatment setup (the random error). 
Positional variations may also be categorised in terms of inter- and intra-fraction errors. 
Various empirical treatment margin formulae and intervention approaches exist to determine 
the optimum strategies for treatment in the presence of these known errors. Other methods 
exist to try to minimise error margins drastically including the currently available breath hold 
techniques and the tracking methods which are largely in development. This paper will 
review anatomical imaging techniques in radiotherapy and how they are used to boost the 
therapeutic benefit of the treatment. 
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It is a very sad thing that nowadays there is so little useless information 
Oscar Wilde 
 
1. Introduction 
Modern radiotherapy uses high technology to try to achieve optimal local tumour 
control whilst minimising treatment side effects to an acceptably low level. Aspects of 
the technology used for this goal include: computer systems for three dimensional 
treatment planning and simulation, with accurate radiation dose deposition models 
and facilities for optimisation of external radiation beam or brachytherapy source 
distribution; computer controlled linear accelerators with dynamic beam collimation 
systems for external beam treatment, or systems such as remote afterloading for 
brachytherapy; and the use of radiation response models to characterise treatment 
outcome and to enable the prediction of treatment outcomes for future patients’ 
treatments. 
  
One of the cornerstones of the whole radiotherapy process is the use of information 
obtained from images. Imaging is needed at every stage of the whole treatment 
process to measure various aspects of the region of the patient being treated. The 
information obtained from the imaging may be used to diagnose the disease and to 
stage it, it may be used to provide input data for the treatment planning process, it 
may be used at the time of treatment to monitor the accuracy of the treatment (i.e. to 
ensure that the delivery of the radiation dose is anatomically correct), and it may be 
used to monitor response to treatment. Thus imaging information obtained about the 
patient is vital to essentially every stage of the radiotherapy process. 
 
Imaging methods in radiotherapy may generally be grouped into two types. The first 
group is made up of those methods that provide anatomical information, that is the 
amount of tissue in the beam but not the status of that tissue, i.e. whether it is viable 
or not. Examples include conventional computed tomography (CT) and magnetic 
resonance imaging (MRI). CT produces a map of x-ray attenuation coefficients at the 
energy used to perform the scan, which with appropriate scaling, gives a good 
approximation to density. MRI most commonly gives a proton density map of the 
tissue. The second group are those imaging methods that measure some functional or 
biological aspect of the tissue being imaged. Examples include radionuclide imaging 
such as single photon emission tomography (SPECT) or positron emission 
tomography (PET) and magnetic resonance spectroscopy (MRS). This review 
discusses only the application of anatomical imaging in radiotherapy. Biological, or 
functional, imaging is considered in the accompanying review by Grosu and Bortfeld 
(Grosu and Bortfeld 2008). Dynamic contrast imaging with CT, MRI and other 
modalities might be argued to be anatomical and functional. For simplicity these 
applications are considered in this review rather than the accompanying one. 
 
Whilst imaging information is used to determine the location of tissue to be treated to 
high radiation dose and, to a great extent, the value of that dose, the imaging process 
has limitations that need to be considered. Firstly, when imaging to define the tumour 
position and extent, the skill of the observer is important in delineating tumour from 
adjacent normal tissue. This is a task which can be extremely difficult as shown by 
variations between imaging techniques and between observers using the same 
technique. Also a given image only represents a snapshot of the patient’s anatomy and 
the position of that anatomy. Thus consideration is needed that the imaging 
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information has uncertainty associated with it, in regard to how typically a picture it 
paints of the position of tissues during treatment, with respect to variations between 
planning scans and treatment, day to day variations during treatment and movement 
effects during a single treatment visit. Other uncertainties exist with regard to how 
clearly the edges of target and non-target tissues may be determined in the image. 
Often these sources of uncertainties are accounted for by using geometric margins, the 
nature of which depend on the type of uncertainty to be accounted for (McKenzie et al 
2000, 2002, van Herk 2004). 
 
The use of imaging for cancer diagnosis and staging is a huge area worthy of review 
in itself and in the limited space of this review the focus will be on the use of 
anatomical imaging once the diagnosis and staging process has been completed. 
Firstly the relationship between imaging, organ localisation, errors and treatment 
margins will be discussed. The next process to be considered is that of treatment 
planning with anatomical imaging, in which, most commonly, CT and MR data are 
used to localise the tumour, then margins for error are defined around the localised 
tumour to produce a target and finally external radiation beams, or brachytherapy 
source positions, are designed to produce the desired dose distribution. Then how 
anatomical imaging contributes to the process of treatment verification, in which the 
anatomical positioning accuracy and dosimetric accuracy of the treatment must be 
measured (and ideally corrected) for each treatment fraction is reviewed. The 
measurement of treatment outcome using imaging is a large area, in which biological 
imaging is playing a greater part. This is beyond the scope of this review. 
 
2. Imaging and treatment uncertainties 
The purpose of anatomical imaging in radiotherapy is to determine the position of the 
target, either to localise and delineate it in the planning stage, or to verify it during 
treatment. The snapshot provided by a single image may not be accurate for all stages 
during the treatment course. Of the various errors present in radiotherapy, several of 
them are attributable to the limitations of the process of planning a treatment based on 
imaging information which involves skilled interpretation and which is obtained 
before treatment: 
1. The anatomical image contains no functional information, hence if the density 
of tumour and normal tissue is similar in the image, definition of the tumour may be 
difficult. 
2. The anatomy in the planning image may not be completely indicative of the 
anatomy during treatment. This may be the result of a change in patient weight or a 
positional different between the planning scan and the mean treatment position. Both 
of these lead to a systematic error in the treatment (Hurkmans et al. 2001, van Herk 
2004). 
3. There are stochastic variations in position from day to day in fractionated 
external beam treatment. Anatomical imaging may be used to measure and/or correct 
for these inter-fraction treatment errors (Hurkmans et al. 2001, van Herk 2004). 
4. Particularly in the case of treatment in the thorax, intra-fraction variations may 
occur as a result of processes such as the breathing and cardiac cycles. Imaging may 
be used to characterise the resultant pattern of motion, so that treatment strategies can 
be designed to account for it (Seppenwoolde et al. 2002, 2007, Shirato et al. 2004b, 
2006). 
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5. Time trends may occur in fractioned treatments. This may be due to weight 
change or the response of tissue to radiation (El Gayed 1993, Hector et al. 2000, 
McDermott et al. 2006). The treatment should ideally respond to such changes. 
 
The various errors have different effects on the treatment and thus may have to be 
dealt with differently. 
 
On the whole, the distributions of systematic and random inter-fraction variations are 
thought to be stochastic and follow a Gaussian distribution (McKenzie et al 2000, van 
Herk 2004). Simulation techniques have been used to calculate margins needed to 
achieve a desired treatment accuracy (minimum percentage volume receiving a 
minimum dose level when summed over all treatment fractions) as a function of the 
systematic and random error distribution (Stroom et al. 1999, van Herk et al. 2000). 
These show the systematic error to be approximately three times as important as the 
random component. Correction strategies have been developed to reduce set-up 
margins. These fall into two categories: online protocols, in which both systematic 
and random errors are reduced by imaging with a test dose at the start of each 
treatment fraction and correcting set-up based on anatomical position (De Neve et al. 
1992, Ezz et al. 1992, Gildersleve et al. 1994); and offline, in which a set of images 
are acquired to determine the systematic error component, which is then corrected at 
the next fraction. Various offline protocols have been developed, including shrinking 
action level (SAL) and no action level (NAL) (Bel et al. 1993, de Boer and Heijmen 
2001, 2007). 
 
The data for breathing motion are generally not normally distributed. Often the 
distribution has a minimum in the centre, with maxima at exhale and inhale and 
shows variability from cycle to cycle (Ford et al. 2002a). Thus it is distinctly non-
Gaussian. However, the fact that the treatment is fractionated ameliorates the problem 
in that a consequence of the central limit theorem is that the average over a sufficient 
number of fractions (typically 30) is Gaussian (Bortfeld et al. 2002). This requires that 
the breathing phase is asynchronous with the treatment delivery system. Nevertheless 
treatment errors may still ensue due to the fact that a single (or a few) snapshot of the 
breathing distribution is sampled when anatomical images are obtained for planning. 
This may introduce systematic treatment errors unless sufficient imaging data is 
acquired to describe the breathing distribution (Evans et al. 2006a). Another potential 
source of error is in the case of IMRT delivery with small segment doses, which can 
lead to beating between the patient motion and beam segment delivery (Seco et al. 
2007). The complexity of intra-fraction motion has lead to a variety of  approaches to 
its management, including using large margins to encompass its extent, breath hold, 
both voluntary and controlled (Lu et al. 2000, Wong et al. 1999,  Remouchamps  et al. 
2003, Hanley et al. 1999, Mageras and Yorke 2004), treatment delivery gating (Kubo 
and Hill 1996, Shirato et al 2000b, Minohara et al. 2000) and delivery tracking 
(McQuaid and Webb 2006). 
 
This discussion has focused on the relationship between the accuracy and quantity of 
the information from anatomic imaging and the margins for error needed. It should be 
emphasised that whilst good anatomical imaging for treatment planning and 
verification helps control many of these errors, there are many sources of error (and 
hence components of the treatment margins) that are not identifiable solely with 
anatomic imaging. Examples include the use of biological imaging to define the gross 
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tumour volume (GTV) (ICRU 50 and 62, Grosu et al. 2005). Biological imaging may 
also improve definition of the margin to determine the clinical target volume (CTV). 
In the nomenclature of ICRU report 62, the set-up margin (SM) may include non-
anatomical components, such as small differences in the co-ordinate frame used in the 
treatment machine and the treatment planning system (Van Herk 2004). 
 
That aside, anatomical imaging has been used to achieve GTV definition and to 
monitor the treatment in various stages to allow small SM and internal margin (IM) 
parameters. A major challenge is to obtain sufficient information to characterise the 
behaviour of tumour and nearby normal tissues in the presence of the types of 
variations listed at the start of this section. 
 
3. Anatomical imaging in treatment planning 
Tumour definition is the first stage in the treatment planning process. Traditionally, 
this has been carried out for some treatment sites using planar x-ray imaging. With the 
advent of volumetric imaging (Hounsfield 1973, Mansfield 2004) and the 
development of methods of achieving complex dose distributions (Brahme 1988, 
Webb 1989, 2000), three dimensional planning using volumetric information is now 
commonplace. In the chain of processes in a radiotherapy treatment, tumour definition 
is the most critical. It is often the link in the chain with the biggest uncertainty and, by 
the very nature of tumour definition, is a process usually carried out once, and 
consequently any errors at this stage propagate systematically throughout the whole 
treatment (Van Herk 2004). 
 
Often the outline of the tumour is delineated manually on the imaging data, relying on 
skilled interpretation to distinguish tumour from non-tumour tissue with low often 
low contrast and unclear boundaries. Studies have evaluated the accuracy of this 
process by comparing outlines produced by sets of observers to measure inter-
observer variability, and repeated outlines by a single observer to measure intra-
observer variability, with results showing large variation in some cases. Methods of 
improving the variability in outlining have included combining different types of 
images, such as CT and MRI, and functional imaging such as PET. The combination 
of imaging methods in multimodality imaging requires registration of the various 
imaging datasets in the frame of reference of the treatment. Many approaches exist in 
the literature, from rigid body registration to deformable morphing of datasets. In 
addition fiducial markers, either external to the patient, or implanted close to the 
tumour have been used either to aid image registration or to improve accuracy of 
delineation in a single modality. Multimodality imaging is generally used to improve 
delineation of a static target by combining information. 
 
Other approaches exist to ameliorate the target definition problem. These include the 
use of fixation systems and implanted markers. Fixation systems include external 
systems such as treatment site dependent boards (Creutzberg et al. 1993), evacuated 
beam bags (Nalder et al. 2001) and frames (Gill et al. 1991) and internal systems such 
as catheters (Fransson et al. 2002) and obturators (Merrick et al. 1999). Implanted 
markers may be fiducial gold grains which may be implanted using a biopsy needle 
(in the case of sites such as the prostate) (Crook et al. 1995). Surgical clips may also 
be used at time of surgery (in the case of the breast) (Machtay et al. 1994, Marks et al. 
1994). 
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The effects of anatomical variations, both day-to-day and intra-fraction, may be 
measured by the acquisition of multiple data sets from the same modality. Day-to-day 
variations may be measured using repeat scans in a process known as adaptive 
radiotherapy or ART (Yan et al. 1998). Intra-fraction variations, such as breathing 
effects, may be measured in CT by scanning sufficiently slowly to encompass the 
whole breathing cycle, but this introduces distortion to the image dataset. 
Alternatively, it may be measured using 4D imaging, in which data is acquired 
throughout the breathing cycle, with a measurement of the breathing phase so that the 
data may be sorted into different breathing phases to measure these variations. 
 
3.1  Computed tomography 
X-ray computed tomography (CT) has been a key component of radiotherapy 
diagnosis and planning from the time it was introduced into clinical practice in the 
early 1970s. A thorough review of x-ray computed tomography may be found in 
Kalender (2006). CT was the first imaging modality to offer detailed imaging of 
internal anatomy in three dimensions and thus to allow accurate determination of the 
spatial location of target tissues relative to non-target tissues. 
 
It’s role has evolved with the use of CT scans to calculate the attenuation of the 
treatment radiation (from an external beam or internal source) and the resultant dose 
distribution in the treatment planning process, along with the generation of reference 
image data for treatment verification in external beam treatment. These reference 
images, known as digitally reconstructed radiographs (DRRs), are projection x-ray 
images generated from the treatment planning computer (Sherouse et al. 1990) and 
may be compared with film or electronic portal images (EPI) for each treatment 
fraction. 
 
3.1.1 Target delineation 
The primary purpose of CT scanning in radiotherapy is to enable delineation of the 
treatment target. This is often a difficult manual task and probably still the main 
source of inaccuracy in radiotherapy (Webb 1993). It is often difficult to obtain a 
ground truth measurement of tumour location and manual outlining is the most 
common method of delineation. Thus the accuracy of the delineation process is 
usually described in several ways: intra-observer outlining variations, inter-observer 
variations, differences between imaging methods (such as between CT and MR and 
between CT and biological imaging (Grosu and Bortfeld 2008)). The results are 
treatment site dependent. Here we summarise a few findings from the literature. A 
more detailed review of volumetric uncertainty in radiotherapy may be found in 
Hamilton and Ebert (2005). 
 
One of the earliest studies of outlining variation was for the prostate and seminal 
vesicles (Fiorino et al. 1998). Five well trained radiotherapists contoured CT images 
of 6 patients scanned in the supine position. Outlining of one patient was repeated 
immediately to measure short-term intra-observer variability. The outlined volumes 
(referred to as inserted volumes) were estimated from lateral and antero-posterior 
projections in the beams eye view. Intra-observer variability was relatively small, 
with an average variation of 5% 1 standard deviation (SD). Inter-observer variation 
was larger 10-80% 1 SD. Variations were largest for the lateral margins of the 
prostate and seminal vesicles and the top and bottom of the prostate. 
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Inter-observer variability in lung tumour delineation has been studied by Van de 
Steene et al. (2002). Five clinicians outlined the gross tumour volume (GTV) on CT 
scans of eight patients. The GTVs were compared in terms of the volume drawn and 
judgement of lymph node invasion. Clinical relevance of variations was evaluated 
using dose calculations in conformal treatment plans. The results showed inter-
observer variations in tumour extent of between 2.8 and 7.3 cm. After common 
review of the lymph node status, it was found that there were 37% false negative and 
22% false positive diagnoses, affecting the target volumes outlined. 
 
Chang et al. (2002) evaluated intra- and inter-observer variability for nasopharyngeal 
carcinoma. 13 patients were outlined by two trained observers. They found small 
differences between observers except in two cases with involvement of the paranasal 
sinuses. Weiss et al. (2003) evaluated target delineation by five radiation oncologists 
and two gynaecologists for three patients with cervical carcinoma. The ratio between 
largest and smallest volumes ranged between 3.6-4.9 and 1.3-2.8 for the radiation 
oncologists and for the gynaecologists respectively. The ratio of common volume to 
maximal encompassed volume (essentially the Jaccard similarity index (Tan et al. 
2005)) was respectively 0.11-0.13 and 0.30-0.57. Mukherji et al. (2005) evaluated 
interobserver variability for eight experienced observers outlining the GTV in 
squamous cell carcinoma of the supraglottic larynx. They found good agreement 
between the observers with a correlation coefficient of 0.81. 
 
3.1.2 CT number calibration 
A CT scan is a map of attenuation coefficient at the energy of the scanner’s x-ray 
tube, which may typically be between 80 kVp and 150 kVp. Data are often displayed 
as Hounsfield units, with air assigned a value of 0 and water 1000 units. The dose 
calculation algorithms used in planning radiotherapy involve determining attenuation 
of the treatment beam or treatment radiation in the tissue of the phantom or patient, 
with correction for variations in tissue type (Cassell et al. 1981). Algorithms currently 
used include Monte Carlo (Reynaert et al. 2001, Verhaegen and Seuntjens 2003), 
collapsed cone kernels (Ahnesjö 1989) and pencil beam kernels (Gustafsson et al. 
1994). The variations in tissue type are modelled with density corrections such as the 
equivalent path length model (O’Connor 1957, Sontag and Cunningham 1978, 
Ahnesjö and Aspradakis 1999). A lookup table is often used in the treatment planning 
system to scale data taken at the CT scanner energy to yield attenuation coefficient at 
the treatment energy (Henson and Fox 1984), which in external beam radiotherapy, is 
often in the megavoltage range. The photoelectric effect is significant at the CT scan 
energies and negligible at the megavoltage energies, with the Compton effect 
dominating.  
 
The values for this lookup table are usually measured with a calibration phantom 
consisting of inserts of different densities. Often the lookup table is expressed as two 
or three linear regions (Seco and Evans 2006). The different balance between 
photoelectric effect and Compton scattering in the two energy ranges is accounted for 
in this process. The first approaches to using kilovoltage energy CT data for 
megavoltage therapy planning were published in the late 1970s (Kijewski and 
Bjarngard 1978 and Parker et al. 1979). More recent work has refined this scaling, 
particularly in the context of accurate Monte Carlo treatment planning (Verhaegen 
and Devic 2005, Reynaert et al. 2007). Refinements have included determination of 
the effects of variations in hydrogen content and extension to higher energies, where 
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pair production becomes important (Seco and Evans 2006). The conversion of 
Hounsfield numbers to stopping powers for hadron therapy has been discussed by 
several authors (Chen et al. 1979, Mustafa and Jackson 1983, Schneider et al. 1996). 
Schneider et al used a stoichiometric approach to generate a table of proton stopping 
power as a function of electron density and Hounsfield number for a range of tissues 
of biological interest. Their results showed changes in hydrogen content are also 
important for calibration for hadron dose calculation. 
 
3.1.3 Image acquisition methods in the presence of motion 
As discussed above the acquisition of a scan for treatment planning purposes 
represents a single snapshot of patient anatomy. Developments of the technology 
since the first demonstration of CT have included faster data acquisition and 
reconstruction time, with scanner rotation times now under half a second (Kalender 
2006) and real-time reconstruction becoming possible with fast computers. In addition 
the advent of multi-slice scanners has enabled the imaging of large anatomical 
volumes in the time of a single rotation. Often the scanner operates in helical mode 
(Kalender et al. 1989) for multi-slice acquisition. A major advantage of helical 
scanning over sequential slice acquisition is that moving objects (such as the heart or 
the breathing lungs) may be imaged continuously with a corresponding control of the 
resultant motion artefacts. At the time of writing 64 and 128 slice scanners represent 
the state of the art. Ultimately it is expected a whole region of the body may be 
imaged with a single rotation (Lewis 2001). An alternative approach to the use of 
multiple fan slices is cone-beam CT, using a two-dimensional detector (Feldkamp et 
al. 1984) rather than a stack of one-dimensional detectors. This approach is 
particularly finding application for treatment verification (Jaffray et al. 1999) as 
discussed later in this article. Advantages of the cone-beam approach include 
potentially shorter acquisition times to image a volume. Disadvantages include greater 
difficulty in generating a scan calibrated in Hounsfield numbers due to the great 
scatter component compared to the more conventional multiple slice detectors 
(Siewerdsen and Jaffray 2001). These improvements in scanner technology allow data 
acquisition with one or a few breath holds for imaging in the presence of lung motion 
(Kubo and Hill 1996). 
 
Whilst imaging with breath hold greatly reduces motion artefacts in imaging 
mediastinum and lung tumours and is expected to aid diagnosis, it does not represent 
an ideal solution for treatment planning. External beam radiotherapy treatments 
generally take several minutes, during which a single breath hold is not possible. 
Several breath holds could be used but questions exist about the reproducibility of 
multiple breath holds (Wong et al. 1999, Cheung et al. 2003). Also there is the need 
for synchronisation to treatment delivery (Kubo and Hill 1996). Technological 
developments are expected to ameliorate this problem, however, as treatment linac 
dose rates increase, partly due to the development of beams without flattening filters 
(Mackie et al. 1999). In the case of brachytherapy a similar situation exists in that the 
treatment takes place over many breathing cycles. 
 
An approach to generate CT data that is more representative of the distribution of 
tissue during the treatment is the use of a slow CT scan (Lagerwaard et al. 2001, 
Wurstbauer et al. 2005), the purpose of which is to sum over the motion in the 
breathing cycle and create in image showing the full tumour extent. Lagerwaard et al. 
evaluated slow CT in comparison with conventional fast spiral scanning. Three 
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conventional scans were also acquired during quiet expiration for 10 patients with 
peripheral lung tumours. Slice thickness was 3 mm, with reconstruction index 2.5 
mm. Three slow CT scans were acquired at 4 s/slice (slice thickness 4 mm, 
reconstruction index 3 mm). The images were registered and several measurements 
were made of the similarity of the volumes. In all cases the slow scan volume was 
larger than the conventional volume with an average increase of 14%. Slow CT was 
also found to be more reproducible. For each scan type, the ratio of the common 
overlapping volume to the volume encompassed by all three CTVs was evaluated (the 
Jaccard index). Values for this index of  54.9% ±12.9% and 62.6% ±10.8% were 
found for conventional fast and slow CT respectively, indicating the slow scans to be 
more reproducible. 
 
Whilst slow CT used in this manner may improve over conventional, fast CT, it has 
the potential disadvantage in that it smears out the effects of movement, providing a 
motion envelope but not a temporal description of that motion. Four dimensional 
computed tomography (4DCT) aims to measure the detailed motion of the tumour and 
thus to generate the probability density function of that motion, which may be used to 
improve treatment accuracy in several ways: 
1. To determine the centre of mass of the motion distribution and allow the 
minimisation of the margin needed to account for that motion (Wolthaus et al. 2006, 
Bortfeld et al. 2002, Evans et al. 2006a); 
2. To allow gating of the treatment in a particular phase of the breathing cycle 
(Balter et al. 1998, Minohara et al. 2000, Vedam et al. 2001, Ford et al. 2002a, 
Ozhasoglu et al. 2002) 
3. To allow tracking of treatment delivery (Webb 2005, McQuaid and Webb 
2006, McClelland et al. 2007). 
 
4DCT is used to acquire a detailed motion model of the patient’s anatomy and 
particularly of the tumour for lung, oesophagus, liver and breast treatment. The 
currently available alternative techniques are subject to artefacts in the presence of 
breathing which 4DCT helps to avoid (Rietzel et al. 2005a, 2005b, Jiang 2006). 
Consider a conventional scan of a breathing object, in which the scanner moves from 
top to bottom of the object when acquiring data. If the motion speed and scan speed 
are similar, then beating effects may occur. This has been illustrated by Rietzel for 
scanning of a moving sphere (figure 1, Rietzel et al. 2005b). Depending on the 
synchronisation between the scanner and the object, the sphere may appear distorted, 
or as a set of disjointed objects. In the case of slow CT discussed above, the object 
distribution is convolved with the motion distribution to yield a blurred estimate. The 
use of such images for radiotherapy treatment planning results in a distorted target 
volume and hence a distorted dose distribution. 
 
The requirement of 4DCT is to acquire raw data, often  in a spiral scan geometry (or 
using the slow scan method), and to measure the position in the breathing cycle as the 
data are acquired (Ford et al. 2002a, Low et al. 2003, Keall 2004a, Underberg et al. 
2004, Van der Geld et al. 2006, Lu et al. 2006b). This approach often involves using 
the cardiac gating input signal to the CT scanner (see for instance Ohnesorge et al. 
2000).  The data are binned into subsets based on breathing position and reconstructed 
separately to yield a set of snapshot images. Several methods of measuring position in 
the breathing cycle have been developed. Measurement of external anatomy has been 
used, including fluoroscopic video imaging of a marker placed on the skin, reported 
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by Wagman et al. (2003) and Keall et al. (2004b). One of the first examples of this 
includes the real-time position management (RPM) system which utilises a marker 
incorporated into a block placed on the patient surface outside the treatment field, 
which is illuminated with infrared and the reflected light detected with a camera (Ford 
et al. 2002a, Wagman et al. 2003). Zhao et al. (2007) have reported the use of an 
optical surface imaging system. Low et al. (2003) used a spirometer. Wolthaus et al. 
(2005) used a thermometer placed in the breathing airflow in the patient’s nostrils. 
Several authors have used strain gauges (Ohara et al. 1989). Kubo and Hill (1996) 
made a comparison of the accuracy of various techniques, including a thermistor, a 
thermocouple, a strain gauge and a pneumotachograph. Movies were acquired at x-ray 
simulation using each method along with the reading from each candidate gating 
system.  The temperature sensor and strain gauge were judged the preferred systems 
based on characteristics such as reproducibility, accuracy, response speed and signal 
to noise ratio. 
 
The respiratory signal used to acquire a 4DCT data set may also be used to acquire a 
CT scan at a single breathing phase. The treatment would be planned and delivered at 
this breathing phase. This would require both CT scanner and treatment room to have 
similar equipment for measuring the patient’s breathing phase. Mageras and Yorke 
(2004) evaluated the use of respiratory gating for treatment in comparison with deep 
inspiration breath-hold (DIBH). They found that approximately half their patients 
could not comply with DIBH and hence there was the need to screen potential 
patients. The respiratory gating used the RPM system. The disadvantages of the DIBH 
approach were that it required active patient participation (hence the problem with 
patients being able to comply) and a breath hold is tolerable for a much shorter time 
than the several minutes taken by a radiotherapy fraction delivery or for a functional 
imaging procedure such as positron emission tomography. The use of treatment gating 
based on the external marker system was found still to require a level of patient effort 
and cooperation. Patients were coached verbally. 
 
Patient coaching is often needed for both breath-hold and respiratory gated 
approaches to CT (including 4DCT) and for treatments planned based on their use. 
This is because breathing is subject to variability, examples of which may be a 
variation in respiratory period or a drift in position (Dawson et al. 2001, 
Seppenwoolde et al. 2002, Mageras and Yorke 2004). This must be minimised to 
reduce artefacts in scanning and, in treatment, to avoid systematic errors introduced 
by differences between planning and treatment. 
 
When gating CT acquisition (either to obtain a scan in a single position or a 4D set of 
scans), the choice of how to define the gating position is important. This is based on 
when one breathing cycle ends and the next starts. The potential for variability in the 
breathing cycle makes this an important choice. Two main approaches have been 
discussed in the literature, phase gating and amplitude gating (Vedam et al. 2001, 
Shen et al. 2003, Mageras and Yorke 2004). In amplitude gating, acquisition is 
triggered when the breathing trace is in a certain position and in phase gating, 
triggering is based on when the breathing is at a given phase angle. 
  
If a 4DCT data set is acquired, it is often desirable to register the position of anatomy 
between the various phases. The advantages of doing this include calculation of the 
summed dose distribution over the whole breathing cycle (Lujan et al. 1999, Coolens 
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et al. 2006, Rietzel et al. 2006). Deformable motion models are generally necessary to 
achieve this, particularly as tumours of the lung and liver are soft tissues, prone to 
deformation (see e.g. Balter et al. 1996). The main approaches adopted for application 
to radiotherapy planning is the use of B-splines interpolants (Rueckert et al. 1999, 
Hartkens et al. 2002). Deformable motion models have been used for CT registration 
in a different context. Christensen et al. (2001) presented an approach to combining 
dosimetry for external beam and intracavity brachytherapy. Three patients with 
locally advanced cervical cancer were treated with CT-compatible applicators and 
underwent five CT scans: before the start of external beam treatment and before and 
after two brachytherapy insertions. Data sets were registered using a viscous fluid 
flow model. Results were analysed in terms of a coincidence index (equivalent to the 
Jaccard index) and found the deformable registration to yield a range 90.6-100% 
compared with 5.2-72.2% without registration. A detailed review of these and other 
methods for deformable image registration may be found in Hill et al. (2001). 
 
The 4DCT approach generally involves establishing the mean trajectory of the target 
over several breathing cycles. This information is then used to plan the treatment 
strategy, but may be subject to variability. Information on the variability has been 
sought in two ways: by the use of fluoroscopy (Chen et al. 2001) and by data 
modelling (Land et al. 2007). Low et al. (2005) developed a 5-dimension model of 
lung motion, as a combination of tidal volume and airflow components to describe the 
motion of a set of points as a function of breathing cycle. For the cases they studied, 
they were able to fit the motion of the points with an average discrepancy of 0.75mm. 
 
3.1.4 Adaptive radiotherapy 
The gating and 4DCT approaches described above are expected to be particularly 
valuable for sites where intra-fraction motion is important, such as the lung or liver. 
Other sites, such as the prostate or bladder, are expected to be more prone to inter-
fraction, or day to day, variation. Again a single scan constitutes a single snapshot 
image which may not be indicative of the anatomy throughout the patient’s treatment. 
 
Yan and colleagues (Yan et al. 2000, Martinez et al. 2001) have proposed a method 
called adaptive radiotherapy (ART) which seeks to ameliorate this problem by 
obtaining a set of CT scans of the patient on different days at the start of treatment 
and designing the target volume using the extra information from this set of scans and 
electronic portal imaging (EPI) on each treatment day. The method was applied to 
prostate cancer patients. In the report by Martinez, 150 patients had an initial CT scan 
from which a treatment plan was made. On the first four days of treatment, CT scans 
and EPI data were obtained. These were used to generate a confidence limited 
planning target volume (cl-PTV) (see figure 2, Martinez et al. 2001). The CT scans 
were first registered to correct for day to day positional variations using bony 
anatomy. To generate the cl-PTV, the convex hull of the extent of the PTV was then 
constructed. The effects of better definition of PTV were modelled to determine the 
dose escalation achievable whilst satisfying dose constraints specified for the rectal 
wall. The conclusion was that ART allowed 5% dose escalation for conformal 
radiotherapy and 7.5% escalation for IMRT. 
 
Pos et al. (2006) have evaluated ART for bladder treatment. For a group of 21 
patients, 5 daily CT scans were acquired immediately before or after irradiation 
(randomly selected to avoid bias), during the first week of treatment and used to 
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construct the cl-PTV (referred to as PTVART). A treatment plan based on this was used 
from the third week and further CT scans taken to measure the accuracy of ART. The 
results were quantified in terms of the treatment volume reduction achievable with 
ART and showed a 40% saving compared with conventional. 
 
3.1.5 CT perfusion 
The problems of target delineation may be reduced by the use of functional imaging, 
particularly in tumours expected to show an enhancement or detriment in uptake 
relative to adjacent normal tissues. This may be from a biological imaging modality 
such as PET (Grosu and Bortfeld 2008) or a contrast agent in a modality such as CT 
or MRI. Contrast agents are starting to be used more frequently in CT scanning for 
radiotherapy planning, particularly for the head and neck region. There is the need to 
consider bulk correction to the CT numbers in the region of the contrast agent for 
accurate dose calculation purposes. The effect of contrast agent on dose calculation 
accuracy has been investigated. Choi et al. (2006) measured the effect of intravenous 
contrast agent on IMRT dose planning for head and neck cancer. Fifteen patients each 
had two scans, one before contrast agent injection and one after. Target volumes and 
organs at risk were contoured on the contrast enhanced scan and IMRT plans created. 
The beams of the plan were copied onto the non-contrast enhanced scans and the dose 
distribution recalculated. Target dose values for the enhanced scans were found to be 
significantly lower than on the non-enhanced scans, but the dose differences were less 
than 1%. Dose to parotid glands and spinal cord were not found to be significantly 
different. 
 
Perfusion measurement involves imaging a time sequence following the rapid 
intravenous bolus injection of a contrast agent (Axel 1980). A review of perfusion CT 
may be found in Miles and Griffiths (2003). One of the most significant studies of 
perfusion CT is the work of Hermans et al. (1999, 2003) for head and neck cancer. In 
the first of their studies (1999) they investigated variability (both intra- and inter-
patient and intra- and inter-observer) and the value of perfusion as a predictive factor 
of local failure after radiotherapy treatment for 41 patients.  They found no significant 
difference between measurements performed by two independent observers. No 
correlation between perfusion rate and tumour volume was found. No significant 
correlation between perfusion rate and local control (p=0.19) was found for the 
patient number studied. In the 2003 study, they evaluated perfusion as a predictive 
factor for local and regional failure in 105 head and neck patients. They stratified the 
patients according to the mean perfusion value and found those with the lower 
perfusion rates had a significantly higher local failure rate (p<0.05). An example of a 
perfusion study is shown in figure 3 (Newbold et al. 2005, Castellano 2006). Fig 3a 
shows a CT slice through the head and neck region, with various regions of interest 
identified and 3b shows the temporal Hounsfield number change follow 
administration of iodine contrast agent (Newbold et al. 2005, Castellano 2006). 
 
Contrast enhanced CT has found particular use in brain imaging (e.g. Nabavi et al. 
1999, Hakime et al. 2007). In radiotherapy, Sidhu et al. (2004) considered delineation 
of brain metastases for radiosurgery treatment planning. They studied the effect of the 
timing between administration of the contrast agent and imaging on the measured 
volume of the lesion. Ten patients were given Omnipaque 300 contrast agent and 
scanned immediately following bolus injection and again with a delay of median 
value 65 min. Results showed an increase in the volume of the metastases in 86% of 
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cases and the consequent choice of a larger collimator. In the case of two metastases 
contrast was no longer visible in the delayed scan. No significant intra- or inter-
observer variability was found. They concluded that the study showed the importance 
of the imaging protocol in the use of contrast enhanced CT. 
 
3.1.6 Metal-induced artefacts 
Metal body implants include artificial limbs, particularly hips (Coolens and Childs 
2003), and fiducial markers implanted to aid target definition. By nature of their high 
attenuation of the kilovoltage x-ray source in the CT scanner they produce artefacts 
that can cause problems in the use of CT data for radiotherapy planning. Firstly the 
attenuation takes the raw signal outside the range at which the Hounsfield unit 
calibration is valid and hence affects dose calculation, and secondly streak artefacts 
from the implant obscure useful soft-tissue structures that may help in target volume 
definition. Various approaches have been taken to reduce the effects of these artefacts. 
Examples include calibration of the CT scanner response by an electron density 
correction (Hensen and Fox 1984) and the use of the stoichiometric method of 
Schneider as described above (Schneider et al. 1996, Coolens and Childs 2003). 
Others have developed filters applied to the raw sonogram data or to the reconstructed 
data (Bal and Spies 2006). Figure 4 (Bal and Spies 2006) shows a CT scan of a 
prostate patient with implanted fiducial markers. The image is shown with and 
without a filter to reduce the severity of the streak artefacts. 
 
3.2  Magnetic resonance imaging 
Magnetic resonance imaging (MRI) has become an important imaging modality in 
radiotherapy planning, complementing the use of CT. It provides several advantages 
over CT, including improved soft tissue visualisation and hence better target 
delineation; it is fundamentally 3D (rather than a stack of 2D slices as in CT); and 
novel techniques are available such as cine MR and magnetic resonance spectroscopy 
(MRS). Disadvantages include the lack of an attenuation correction map for dose 
planning; geometric distortion; and cost. MRS is a biological imaging modality and so 
not within the remit of this review. A detailed review of MRS in radiotherapy 
treatment planning may be found in Payne and Leach (2006). 
 
3.2.1 Target delineation 
Several studies have evaluated MRI for target volume definition and often the results 
have been expressed in terms of comparison between MRI and CT volumes and their 
treatment planning consequences. 
 
For the prostate, MRI and CT were compared by Roach et al. (1996). Ten patients 
were scanned with T1 weighted MRI and CT (without the use of contrast agent). The 
bony anatomy on the images was matched and the measured prostate volumes 
(excluding seminal vesicles) compared. Retrograde urethrograms were used to assist 
with definition of the inferior border of the prostate (Roach et al. 1993). The mean 
prostate volume was found to be 32% larger on average (range -5-63%) for CT. 
Discrepancies in volume definition were associated with four regions in the prostate: 
the posterior part, the posterior-inferior-apical part; difference in apex position 
between the urethrogram and MRI; and regions corresponding to the neurovascular 
bundle. They discussed using contrast enhancement in the CT scan as an alternative. 
Rasch et al. (1999) compared MRI and CT for delineation of prostate and seminal 
vesicles in 18 patients. Proton density MRI scans were taken in axial, coronal and 
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sagittal planes and compared with CT. As with Roach’s study, the CT volumes were 
found to be larger, in this case by 43% (p < 0.005) for axial scanning. Axial MRI 
volumes were, on average, found to be 1.09 and 1.19 times the coronal and sagittal 
volumes, respectively. Systematic differences between the positions of the apex of the 
prostate and seminal vesicles were evaluated, with both found to be 6-7 mm closer to 
the centre of the prostate on the axial MRI scans, with coronal MRI scans agreeing to 
within 1.5-3 mm on average. Variability between three observers was measure and 
found to be a smaller factor than choice of scan modality. They recommended axial 
MR should be used for delineation, with a combination of axial and coronal scans in 
case of doubt, and the CT scan used for treatment plan dose calculation. Debois et al. 
(1999) found broadly similar results using T2 weighted axial and coronal MRI data, 
with the average CT volume 46% bigger than on axial MRI for 9 patients, plus one 
patient showing a larger volume on MRI than on CT. Inter-observer variability in the 
location of the apex was measured for three observers and found to be best for coronal 
MRI and worst for CT. The effect on planned dose to rectum was compared for the 
modalities and it was found that the volume of rectum on the MRI scan receiving 
more than 80% of the prescribed dose was reduced by 23.8% on average compared 
with CT organ delineation. Jackson et al. (2007) found a 14% bigger prostate volume 
for CT (11 patients) and that the planned percentage of rectum treated to doses above 
45Gy (prescribed treatment dose 70Gy) was significantly lower for T2-weighted MRI 
compared to CT. Khoo and Joon (2006) reviewed new developments in MRI for 
target volume delineation. Figure 5 (from Khoo and Joon) shows a CT slice through a 
patient’s prostate and the corresponding T2-weighted MRI slice, revealing better 
visualisation of organ boundaries. 
 
MRI has the advantage that rapid images may be acquired without the dose associated 
with cine CT. An example of the use of this in radiotherapy is the evaluation of rectal 
distension and rectal movement on prostate position using cine MRI (Padhani et al. 
1999). 55 patients were scanned axially using a T1-weighted spoiled gradient-echo 
sequence and a T1-weighted turbo-FLASH sequence every 10 s for 7 m. 24 patients 
received bowel relaxants before imaging.  Rectal movements were seen in 51% 
patients overall. A smaller percentage of those receiving relaxants showed movement, 
but the result was not statistically significant. Incidence of rectal movement correlated 
with degree of rectal distension, but the magnitude of that movement did not. The 
rectal movements correlated well with prostate movement. Prostate movements in the 
anterior-posterior direction were seen in 29% patients and in 16% of patients the 
movement was greater than 5 mm. The conclusions of the study were that rectal 
movements result in displacements that are significant in magnitude for radiotherapy 
planning over a time period similar to the delivery of a radiotherapy fraction. 
 
Ten Haken et al. (1992) evaluated MRI delineation of brain tumours in 15 patients (5 
with low grade astrocytomas and 10 with higher grade glial tumours). The datasets 
used consisted of CT scans with iodinated intravenous contrast, and a variety of MRI 
scans: axial T2 weighted, axial T1 weighted and coronal T1 weighted. The T1 
weighted scans were taken with gadolinium contrast. Two components to the target 
volume were defined on each imaging modality: a microscopic volume defined by 
edema on CT and increased T2 signal on MRI; and a macroscopic/boost volume 
defined by contrast enhancement on CT and T1-weighted MRI. MRI defined volumes 
(both microscopic and macroscopic) were larger than for CT. The composite volume, 
defined as the sum of CT and MRI, had just 50-55% overlap between CT and MRI. 
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The PTV (made by expanding the microscopic volume by 2 cm in all direction and 
the macroscopic volume by 1 cm) showed greater overlap with 79% and 69% 
respectively. Weltens et al. (2001) studies interobserver variability in brain tumour 
definition, combining CT and MRI for five patients with inoperable supratentorial 
tumours. Nine physicians participated in the study. A larger variation in outlining was 
found. Figure 6 (from Weltens et al. 2001) shows an example GTV delineation 
variation between the observers for the two modalities. The ratio of largest to smallest 
CT GTV volume outlined was between 1.7 and 2.8. Use of MRI plus CT still 
produced a large variation in the volume ratio – between 1.5 and 2.4. The volumes 
delineated on the combined scan data was on average 17% higher than on CT alone. 
 
Other treatment sites where MRI target definition has been evaluated include base of 
skull meningiomas (Khoo et al. 2000), central nervous system (Aoyama et al. 2001) 
and liver (Teefey et al. 2003). 
 
3.2.2 Image distortion correction 
Imaging data for radiotherapy treatment planning should have good geometric 
accuracy, as distortion will contribute to systematic errors in the positioning of tissues 
and potentially dose calculation errors. It is well known that MRI system suffer from 
geometric distortions due to issues such as variations in magnetic field strength, 
gradient field non-linearity and susceptibility effects. Distortions have been shown to 
range from typically 0.2 to 5 mm as the distance from the centre of the magnetic field 
increases from 5 to 10 cm Prott et al. (2000). For these reasons there is much interest 
in quantifying this distortion, establishing its effect on treatment dosimetric accuracy 
and developing methods to correct for it. 
 
Kooy et al. (1994) demonstrated the use of chamfer matching to fuse CT and MRI for 
radiosurgery planning. They presented two cases, an acoustic neurinoma and a 
pilocytic astrocytoma. They concluded that MRI is necessary in stereotactic therapy, 
with superior diagnostic quality, but with poor geometric fidelity. Prott et al. (2000) 
investigated the effects of MRI distortion on radiotherapy treatment planning. They 
investigated 27 MRI units. The distortions were found to cause small variations in 
maximum dose (±0.5%). Changes in the 95% isodose volume were seen (25% cases 
showed an increase and 60% a decrease). Organ at risk doses variations were found to 
be comparable to those in the PTV. 
 
Several groups have evaluated methods of distortion correction for treatment 
planning. Tanner et al. (2000) described the removal of MRI system distortions using 
a geometric phantom consisting of orthogonal arrays of water-filled 
polymethylmethacrylate tubes. Figure 7 shows an uncorrected coronal image of the 
phantom. Results showed that distortions were over 10 mm for larger distances off 
axis. Reproducibility of the measurements was of order 0.1mm indicating the 
accuracy expected from such a calibration procedure. Most current clinical MRI 
systems have 1.5T field strength. Petersch et al. (2004) evaluated distortion in a 0.2T 
system and its effects on treatment planning. They found that using the phantom 
calibration method to remove system effects reduced maximum distortion from 28.0 
to 13.7 mm with mean distortion reduced from 2.2 to 0.6 mm and 95% of points with 
distortion of less than 1.5 mm. Object induced distortions were also investigated and 
found to be a second order effect. Wang et al. (2004a, 2004b, 2004c) studied 
geometric distortion in several models of MRI systems. They measured distortion 
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using a purpose built phantom consisting of a 3D grid of crosses. They found similar 
results to other investigators, with maximum distortion errors between 10 and 25 mm 
and corrected images accurate to better than 0.8 mm. 
 
3.2.3 Treatment planning using MRI alone 
In treatment sites without significant tissue inhomogeneity, there is the potential to 
use MRI alone for treatment planning, with a bulk density correction applied for dose 
calculation in the absence of an electron density map from CT.  This has been 
investigated for prostate cancer (Lee et al. 2003, Petersch et al. 2004). For a 1.5T 
system, Lee showed distortions of 2 mm in the vicinity of the prostate for FLASH 3D 
T1-weighted images and that the use of bulk density assignment to water and bone 
produced treatment plans with similar percentage volumes of rectum receiving greater 
than 50% dose to CT for conformal treatment. The plan to extend this work to T2-
weighted imaging, with greater contrast, was discussed. Petersch investigated the use 
of the 0.2T resistive MRI system discussed above. Dose calculations, with all tissues 
taken as water equivalent, showed agreement with CT of 1% in the dose at the 
normalisation point in four out of five cases studied. 
 
3.2.4 MRI contrast enhanced, perfusion and diffusion imaging 
MRI perfusion and diffusion imaging have been evaluated for imaging cancer. A 
review of the underlying physical principles may be found in Thomas et al. (2000).  
 
Rouviere et al. (2004) evaluated gadolinium dynamic contrast enhanced (DCE) MRI 
versus T2-weighted MRI for localisation of intraprostatic lesions in 22 patients. They 
correlated their findings with biopsy results and measured variability between three 
observers. The DCE imaging produced better agreement with biopsy and better 
interobserver agreement than the T2-weighted images. Storaas et al. (2004) also 
evaluated DCE MRI for prostate localisation. 28 patients were imaged with  
gadolinium DCE T1-weighted 3D echo planar imaging and a T2-weighted turbo spin 
echo (TSE) sequence. Comparison was also made with histology from resected 
specimens. No statistically significant improvement in localisation of prostate or 
seminal vesicles was found by adding the DCE information and they concluded that 
the DCE sequence did not improve tumour localisation compared to the T2-weighted 
sequence. 
 
Sumi et al. (2003) evaluated the use of diffusion-weighted MRI to detect metastatic 
cervical lymph nodes in head and neck cancer patients. Diffusion-weighted echo 
planar imaging and T1- and T2-weighted MR imaging sequences were performed on a 
set of patients’ lymph nodes. The results were correlated with histology. The apparent 
diffusion coefficient (ADC) was found to be significantly greater in metastatic lymph 
nodes than in benign lymphadenopathy (P<0.01), with nodal lymphomas having the 
lowest ADC values. Applying an ADC criterion for detection of metastatic nodes 
yielded a negative predictive value of 71% and a positive predictive value of 93%.  A 
fuller review of diffusion MRI to assess cancer therapeutic efficiency may be found in 
Chenevert et al. (2000). 
 
MRI perfusion has been used to study blood flow in brain tumours (Cha et al. 2002, 
Keston et al. 2003). Wenz et al. (1996) compared perfusion in low grade astrocytomas 
and normal brain tissue before and after radiotherapy. Results showed a significant 
reduction in blood volume within the tumours after irradiation, with an insignificant 
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reduction for gray and white matter outside the target volume. By comparison a 
significant reduction in blood volume for gray and white matter was observed after 
whole-brain irradiation, suggesting perfusion MRI may be used to monitor tumour 
response and normal tissue effects in radiotherapy. 
 
3.3  Ultrasound 
Ultrasound has been used to assist target definition in treatment planning, particularly 
in the absence of CT data. Some of these applications are being replaced by CT and 
MRI, but the development of new technology, including 3D scanning (Treece et al 
2003) and tissue characterisation imaging (Burnside et al. 2007) mean that ultrasound 
has a important contribution to anatomical imaging for radiotherapy planning. 
Ultrasound has been used in several target localisation studies for post-lumpectomy 
breast radiotherapy. DeBiose et al. (1997) demonstrated localisation of the 
lumpectomy cavity for interstitial brachytherapy; Helyer et al. (1999) investigated the 
determination of the depth of the tumour bed and consequent selection of electron 
boost energy, and Coles et al. (2007) made a comparison of 2D and 3D ultrasound 
with CT for localisation of the tumour bed. They concluded that co-registration of 3D 
ultrasound with planning CT data can be used to yield additional information on the 
size and position of the tumour bed to be incorporated into the planning volumes. 
Featherstone et al. (1999) used ultrasound to localise the ovaries for radiation-induced 
ovarian ablation as part of breast cancer treatment. Orecchia et al. (2007) used 
ultrasound to measure the treatment of prostate cancer with intraoperative 
radiotherapy (IORT). 11 patients were treatment with pelvic lymphadenectomy, 
prostate IORT (with an electron beam from a mobile linear accelerator) and radical 
retropubic prostatectomy. Prostate thickness and depth of rectum were measured with 
ultrasound and used to quantify the dose distribution to the prostate and rectum. 
 
Real-time transrectal ultrasound (TRUS) has been used to enable image-guided source 
implantation in brachytherapy treatment of localised prostate cancer (Blasko et al. 
1993, 1995, Hoskin and Bownes 2006, Lawton et al. 2007). Blasko et al. presented a 
method for transperineal permanent implantation of 125I and 103Pd seeds. In their 
method, they took a set of transverse ultrasound images covering the prostate volume 
and determined the optimum seed distribution. The seeds were then implanted under 
biplanar ultrasound guidance to enable the operator to visualise needle placement in 
both transverse and sagittal planes and to see prostate movement. Post-implantation, a 
CT scan was taken to enable dose calculation. They contrasted their method with the 
older retropubic approach and concluded that better dose homogeneity, greater 
reproducibility and a larger treatment volume are achievable with the new method. 
469 patients were treated with the image-guided technique. Follow up for a median 
time of 37 months showed favourable prostate-specific antigen (PSA) levels. Lawton 
et al. (2007) recently presented results of a multi-centre, phase 2 study, in which 95 
patients were treated with the ultrasound-guided transperineal method. Patients were 
followed up for a mean time of 5.3 years. Survival at 5 years was 96.7%. 6% had 
biochemical failure. They concluded that the outcome results were comparable to 
other brachytherapy data and the results of surgery and external beam radiotherapy. 
 
Ultrasound guidance has also been used to aid source implantation in brachytherapy 
of gynaecological malignancies. Stock et al. (1997) presented the use of TRUS image-
guided for a series of cases (4 cervical, 2 endometrial and 1 vaginal). Sahinler et al. 
(2004) demonstrated the use of transvaginal ultrasound guidance for placement of 
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tandem applicators for cervical cancer treatment. The ultrasound scan was used to 
judge the likely difficulty of applicator insertion and found to have good predictive 
value. 
 
4. Anatomical imaging in verification 
Anatomical imaging for treatment verification is an essential part of the radiotherapy 
process. Recent years have seen significant technological development of a number of 
complementary approaches to this problem. The essential goal of treatment 
verification is to minimise and quantify any differences between the treatment as 
planned and delivered. Quantification of differences is in terms of the geometrical 
errors discussed above and ultimately the dose distribution and predicted impact on 
treatment outcome. The use of imaging of soft-tissue for verification, particularly in 
external beam radiotherapy, is often referred to as image guided radiotherapy (IGRT) 
verification (Jaffray 2007) or target of the day (Mackie et al. 1999). The term IGRT 
has also been used in terms of planning using functional imaging (Chao et al. 2001) 
and using imaging dynamically in a procedure (Zamorano et al. 1987) such as the 
TRUS methods discussed in the previous section. 
 
A wide variety of techniques have been applied to IGRT, including: 
1. Megavoltage x-ray electronic portal imaging (EPI) 
2. Kilovoltage x-ray portal imaging 
3. Kilovoltage CT (most commonly conebeam, but also CT on rails in the 
treatment room) 
4. Megavoltage CT (including Tomotherapy) 
5. Electromagnetic marker tracking 
6. Ultrasound 
7. Optical methods 
 
The portal imaging methods, 1 and 2, being projection based, are good for imaging 
bony structure. In order to determine soft-tissue positioning, they are generally used in 
conjunction with surrogate, fiducial markers. Thus they are invasive, but have the 
potential to be used for tracking intra-fraction motion if sufficiently rapid data can be 
acquired. The CT methods, 3 and 4, involve pre-treatment scanning, allow soft tissue 
visualisation, facilitate adaptive radiotherapy and provide information similar to the 
data used to plan the treatment. They are useful for determining inter-fraction 
variations. The first four methods all entail extra dose to non-target tissues in the 
patient (except the use of megavoltage portal imaging of the delivered beam). 
Electromagnetic tracking, ultrasound and optical imaging entail no extra dose. 
Electromagnetic marker tracking provides a real-time 3D movement map of 
implanted fiducials. Ultrasound allows soft tissue visualisation but requires a skilled 
operator, scanner set-up and may be prone to tissue distortion from the probe 
pressure. Optical systems are completely non-contact, but only allow surface imaging 
and hence must be used with imaging of internal anatomy and/or a model of the 
relationship between motion of internal and external anatomy. The utility of 
ultrasound and optical imaging are treatment site dependent. Megavoltage portal 
imaging and the two CT methods may be used to provide treatment dosimetry 
estimation. A summary of some of the properties of these imaging methods is 
presented in table 1. Newer verification techniques are being developed including the 
incorporation of an MRI scanner into the external-beam treatment machine 
(Raaymakers et al. 2004). 
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4.1  Megavoltage portal imaging 
Several excellent reviews of megavoltage EPI have been written (Boyer et al. 1992, 
Herman et al. 2001, Langmack 2001, Antonuk 2002, Herman 2005, Kirby and 
Glendinning 2006). EPI has the attraction that it images the actually treatment beam 
(hence may involve no extra dose) and provides some information on internal 
anatomy. The fact that it provides projection images using higher x-ray energy limits 
the quality of the information available, however. Several imaging technologies have 
been applied to EPI (see the reviews of Boyer et al. and Antonuk), but the majority of 
currently used systems are based on amorphous silicon flat panel imagers (FPIs) 
(Antonuk et al. 1992), with one system based on a CCD camera (deBoer et al. 2000). 
FPIs are used for many of the alternative x-ray verification systems including 
kilovoltage portal imaging and conebeam CT (CBCT). 
 
In terms of anatomical imaging, the information most commonly available is the 
position of bony anatomy relative to the radiation field edge. Hurkmans et al. (2001) 
made a thorough review of the literature on the measurement of random and 
systematic inter-fraction treatment errors for a variety of treatment sites: head and 
neck, prostate, pelvis, lung and breast. Soft tissue imaging has been achieved using 
implanted fiducial markers as a surrogate (Vigneault et al. 1997, Nederveen et al. 
2002, 2003, Ford et al. 2002a, Aubin et al. 2003, Chen et al. 2007). Nederveen et al. 
(2003) compared the measurement of positional errors based on bony anatomy with 
the use of fiducial markers. They evaluated 2025 portal images in comparison with 
CT for 23 patients. Standard deviations in systematic marker position deviations of 
2.4 to 4.4 mm were found. An offline correction protocol (Bel et al. 1993) reduced 
this to under 1 mm. The use of bony anatomy in the correction protocol, in place of 
the fiducials, reduced the set-up error by 50% in two directions, but no reduction was 
found in the cranio-caudal direction. This study showed the value of the fiducial 
markers and that large set-up margins may still be needed if basing corrections bony 
anatomy. McDermott et al. (2006) showed how changes in anatomy could be 
determined using difference images. Examples presented include progressive changes 
in lung cancer patients in response to irradiation. 
 
Other applications of EPI include dosimetry, which may be empirical measurement 
(Hansen et al. 1996, Pasma et al. 1999, McDermott et al. 2004, Greer 2005, Winkler 
et al. 2005, Wendling et al. 2006) or model based (Spies et al. 2000, McCurdy et al. 
2001, Spezi et al. 2002, Siebers et al. 2004, Parent et al. 2006) and IMRT verification 
(Warkentin et al. 2003, Van Esch et al 2004, Wendling et al. 2006). Commercially 
available detectors have low quantum efficiency (QE) at 1-2%. Several groups are 
developing higher efficiency systems using approaches such as thick scintillators or 
structured high density material (Mosleh-Shirazi et al. 1998a, Pang and Rowland 
2002, Sawant et al. 2002, 2005, Evans et al. 2006b) to increase the efficiency by an 
order of magnitude, with the challenge of maintaining spatial resolution. 
 
4.2  Kilovoltage portal imaging 
Kilovoltage projection imaging has long been used in radiotherapy in the x-ray 
treatment simulator. With the advent of CT simulation (see e.g. Nishidai et al. 1990) 
the role of the conventional simulator has changed and several groups have used 
simulator fluoroscopy to measure intra-fraction breathing motion. Malone et al. 
(2000) measured prostate motion using fiducial markers and Poggi et al. (2003) 
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evaluated marker migration. Chen et al. (2001) and Sixel et al. (2003) evaluated 
tumour motion in lung patients. This was carried out without markers, based on image 
intensity. The purpose of such studies was to determine the margins needed to account 
for intra-fraction motion. 
 
By incorporating diagnostic-energy x-ray imaging into the treatment room, it is 
possible to acquire kV portal images for treatment verification. As early as 1985 a 
diagnostic x-ray set was mounted on a treatment linac (Biggs et al. 1985). Several 
authors have compared MV and kV portal imaging for set-up correction (Jaffray et al. 
1995, Pisani et al. 2000). The early studies were with film or camera based systems. 
These have been replaced by the FPI systems. Manufacturers are starting to provide 
kV imaging systems on the treatment unit to enable kV projection and CBCT imaging 
(Jaffray 2005, Yoo et al. 2006b). These are generally mounted at right angles to the 
treatment beam. 
 
Systems with one kV imager provide 2D information. The combination with 
orthogonal MV imaging can provide 3D information. A favoured approach is to 
incorporate at least two kV systems to enable stereoscopic 3D imaging. Up to four 
systems are installed to enable imaging at gantry angles which might obscure one of 
the systems. These systems are often used in conjunction with implanted fiducial 
markers to enable tracking of mobile tumours, such as in the lung or liver. 
 
The first example of this approach was in a robotic radiosurgery system (Adler et al. 
1999, Murphy et al. 2003). This used two orthogonal, floor-mounted FPI detectors 
and ceiling mounted x-ray sets. Yin et al. (2002) reported the use of a similar system 
for intensity modulated radiosurgery of spinal tumours. Massachusetts General 
Hospital have also developed a system with two x-ray tubes mounted 45° from the 
treatment head (Berbeco et al. 2004). These systems also use infrared tracking to 
complement the x-ray systems and allow tracking between x-ray verification images, 
thus reducing x-ray dose (Jiang 2006, Jin et al. 2007).  
 
The group of Shirato (Shirato et al. 2000a, 2000b, 2004b, 2006, Shimizu et al. 2001, 
Seppenwoolde et al. 2002) developed a system with four floor-mounted x-ray tubes 
with ceiling-mounted x-ray image intensifiers that imaged at 30 frames/s. A 
photograph of the system is shown in figure 8. A 2mm gold fiducial marker implanted 
in the body was imaged using x-ray energies of 50 to 120 kVp. The dosimetric 
consequences of using this system in fluoroscopic mode for real-time tumour tracking 
were evaluated. The surface dose was found to be between 28 and 980 mGy/h, 
depending on kVp and x-ray pulse width (Shirato et al. 2004a).  
 
4.3  Kilovoltage CT 
Kilovoltage CT in the treatment room provides 3D anatomical information including 
soft tissue and thus provides advantages over the portal imaging methods described 
above. However the scan is generally obtained prior to therapy and hence has limited 
information on intra-fraction variations. Two approaches have been developed: the 
incorporation of a diagnostic CT scanner in the treatment room and the attachment of 
a kilovoltage source and FPI on the treatment linac and scanning in conebeam 
geometry (Feldkamp et al. 1984). 
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The use of diagnostic scanners in the treatment room is achieved by moving the 
treatment couch between the treatment machine and the CT scanner and is often 
referred to as CT on rails. Court et al. (2003) evaluate the positional accuracy of such 
a system in terms of the component errors introduced by the need to move the couch. 
They evaluated two positioning protocols: one relying on the mechanical integrity of 
the system; and one using radio-opaque markers in the treatment couch. The first had 
positional accuracy of 0.6-0.7 mm and the second better than 0.5 mm. This system is 
further described in Ma and Paskalev (2006). Kuriyama et al. (2003) evaluated an 
alternative system and found comparable accuracy of 0.4 mm. 
 
The duel-energy imaging system of Jaffray discussed above was used to take CBCT 
scans on the treatment unit, using an x-ray tube at 90° to the treatment beam and a 
camera-based imager initially (Jaffray et al. 1999) and a FPI ultimately (Jaffray and 
Siewerdsen 2000, Jaffray et al. 2002). Ding et al. (2007) describe a similar system. 
Létourneau et al. (2005) demonstrated the use off the conebeam geometry to produce 
images with high spatial resolution in all three directions with a sagittal slice through 
a prostate patient showing good definition of bladder, prostate, seminal vesicles, 
rectum and sigmoid colon (see figure 9). One of the potential disadvantages of the 
conebeam geometry is the larger amount of scattered x-rays, which may increase 
noise in the reconstructed images and hence reduce detectability of low contrast 
objects (Endo et al. 2001). In addition it may be desirable to use the images for 
dosimetric verification, either by inputting the images to the dose calculation 
algorithm on the treatment planning system, or using a transit dosimetry approach 
(Hansen et al. 1996, McNutt et al. 1996). The scattered radiation may affect the 
Hounsfield number calibration, thus introducing uncertainty to the dose calculation 
(Malušek et al. 2005). Siewerdsen et al. (2004) demonstrated the use of anti-scatter 
grids and Jarry et al. (2006) demonstrated the use of a Monte Carlo based correction 
method, which improved calibration for a variety of phantom materials. Yoo and Yin 
(2006a) evaluated the dose planning accuracy of uncorrected images and showed that 
in most cases the error was below 1%, with 3% error in an inhomogeneous phantom. 
Patient doses have been evaluated and found to be of order 1-3cGy (Islam et al. 2006, 
Amer et al. 2007). Solutions to problems identified in conventional CT have also been 
developed for CBCT, including metal artefact reduction (Zhang et al. 2007) and 
correction for respiratory motion (Sonke et al. 2005, Schreibmann et al. 2006). 
Several papers have demonstrated clinical applications of CBCT (Sykes et al. 2005, 
Henry et al. 2006, White et al. 2007, Létourneau et al. 2007). 
 
4.4  Megavoltage CT 
Megavoltage CT (MVCT) uses the treatment beam to make a scan and hence provides 
an alternative method of treatment-time CT without the need for additional x-ray 
sources or detectors. The first implementations used a single row of high QE elements 
comprised of photo-diodes and scintillators, scanned in third generation geometry 
(Simpson et al. 1982, Swindell 1983, Brahme et al. 1987, Nagakawa et al. 1991, 
Lewis et al. 1992). Later systems used conebeam geometry, either based on a high QE 
scintillator array coupled to a camera (Mosleh-Shirazi et al. 1998a, 1998b) or an FPI 
(Hesse et al. 1998, Ford et al. 2002b, Sillanpaa et al. 2005, Pouliot et al. 2005). One 
system has combined high QE with the use of an FPI (Seppi et al. 2003). 
Tomotherapy uses MVCT for verification (Mackie et al. 1999, Ruchala et al. 1999, 
2000, Forrest et al. 2004, Meeks et al. 2005). The detector used is a high-pressure 
xenon ionisation chamber. 
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The limitations of MVCT in comparison with diagnostic energy CT arise from the 
lower quantum efficiency of a detector at the megavoltage energy and the lower 
intrinsic contrast between the various tissues. However trade-offs may be made in 
terms of quantities such as the spatial resolution required, to limit the dose needed 
(Simpson et al. 1982). Advantages of MVCT over conventional CT include the 
reduction of artefacts due to high Z materials such as dental fillings (Pouliot et al. 
2005, Lu et al. 2006a). Also as the images are attenuation maps in the treatment beam, 
MVCT may readily be used for treatment planning dose calculation and dose 
verification without the need for a conversion table as in conventional CT (Simpson et 
al. 1982, Aoki et al. 1990, Kapatoes et al. 2001, Langen et al. 2005, Morin et al. 
2007). Yin et al. (2005) combined projections from kV and MVCT systems at 90° to 
each other, with the potential to utilise the best features of both systems. 
 
Meeks et al. (2005) presented a detailed characterisation of the Tomotherapy MVCT 
system. They showed images could be acquired with doses as low as 1.1 cGy 
(measured in a 20 cm diameter cylindrical phantom). Langen et al (2005) presented 
the use of this system for daily prostate localisation, comparing features in MVCT and 
planning CT scans. Sidhu et al. (2003) discussed correction of the treatment plan to 
account for the MVCT dose. Their system used an FPI to acquire 21 conebeam 
geometry projections at 10° intervals, giving 52.5 cGy in total. The dose level was 
determined by the requirement of the EPID to receive at least 2.5 cGy per projection. 
They showed good dose distributions could be achieved if the MVCT is considered in 
the plan optimisation for IMRT. Pouliot et al. (2005) used an FPI to achieve 
conebeam images with 0.02-0.08 monitor units per projection, to produce images with 
between 5 and 15 cGy. Comparisons between MVCT and treatment CT scans were 
shown for a head and neck cancer patient. They also showed improvement in image 
quality by removing the flattening filter from the beam. 
 
4.5 Electromagnetic marker tracking 
An approach to the use of surrogate fiducial markers that does not require an x-ray 
dose is the use of implanted electromagnetic transponders (Balter et al. 2005, 
Willoughby et al. 2006, Kupelian et al. 2007, Litzenberg et al. 2007). The 
transponders used are larger than radio-opaque markers, being cylinders 8 mm long 
and 1.85 mm diameter (radio-opaque markers are typically 1 mm length e.g. 
Litzenberg et al. 2002) and are imaged, at a rate of 10Hz, with a magnetic array 
placed close to the patient surface. Balter et al. (2005) showed the system to provide 
submillimeter accuracy under a variety of conditions. 
 
The use of this system has been demonstrated for prostate localisation. Willoughby et 
al. (2006) presented the first data resulting from imaging sets of 3 transponders 
implanted into 20 patients. For 11 of the cases, transponder measurements were 
compared with kV radiographic imaging of the transponders. The average 3D 
difference was 1.5 ± 0.9 mm. Patients were also tracked for 8 minutes and, in some 
cases, showed organ motion in excess of 1 cm for a large part of this period. 
Litzenberg et al. (2007) investigated the potential for marker migration for all 20 of 
these patients and showed that 58 of the 60 markers did not migrate, indicating similar 
long term stability to radio-opaque markers. 
 
4.6  Ultrasound 
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Various ultrasound systems have been developed for soft-tissue verification in 
radiotherapy, with particular application to prostate localisation. The first systems to 
be implemented consisted of a B-mode trans-abdominal probe attached to a precision 
tracking arm (Huang et al. 2002, Chandra et al. 2003, Little et al. 2003, Trichter and 
Ennis 2003, Langen et al. 2003, Peignaux 2006). Real-time images were displayed, 
overlaid with outlines from the planning CT scan. The set-up error was determined by 
moving the outlines in sagittal and transverse directions until the ultrasound scans 
matched with them. 
 
Several authors have evaluated the accuracy of such systems in comparison with EPI 
and have generally found differences.  Trichter et al. found systematic shifts between 
the two imaging methods of typically 3 mm in each direction, with a large spread of 
values. Others have compared ultrasound position measurements with fiducial 
markers on EPI (Langen et al. 2003, Van den Heuvel et al. 2003). Again they show 
significant systematic differences. Langen reported differences between ultrasound 
and marker alignment of 0.2 ± 3.7 (1 standard deviation), 2.7 ± 3.9 and 1.6 ± 3.1 mm 
in anterior-posterior, super-inferior and lateral directions respectively. They also 
found inter-observer variability in the use of the contour alignment system. The 
significant differences seen in these studies have been attributed to the effects of 
probe pressure distorting the prostate anatomy. Artignan et al. (2004) made a 
systematic study of this effect. Ten volunteers were imaged with a 3D probe fixed 
with a rigid arm, which was moved stepwise towards the prostate and further images 
obtained. The largest movement was seen in the posterior direction. A probe 
displacement of 1.2 cm was needed to get good image quality, resulting in an average 
prostate displacement of 3.1 mm. McGahan et al. (2004) made a similar study and 
found similar results. Treece et al. (2002) have developed a method of correcting for 
probe pressure effects. Cury et al. (2006) compared two approaches to ultrasound 
verification using a 3D probe system. The first approached (named cross-modality) is 
equivalent to the techniques described above and the second involves measuring shifts 
by comparing ultrasound scans on different days. Significant differences were found – 
6 mm in the superior-inferior direction. They recommended the use of the second 
approach. Several automatic methods have been developed to outline the prostate in 
3D ultrasound scans (Wang et al. 2003, Hu et al. 2003) 
 
Although mostly used for prostate radiotherapy, studies of ultrasound localisation 
have been carried out in other sites. Coles et al. describe localisation of the tumour 
bed in breast radiotherapy using a 3D reconstruction method (Prager et al. 2002). The 
post-lumpectomy cavity was visible in all 3D ultrasound images. Comparison with 2D 
ultrasound showed the 3D system to be significantly superior.  
 
With the advent of fast 3D scanners, several groups are developing real-time tracking 
systems (Pagoulatos 2001, Kolen et al. 2004). Two groups have discussed the use of 
such as system to gate treatment delivery (Sawada et al. 2004, Hsu et al. 2005). The 
ultimate goal of such approaches would be to gate treatment delivery based on intra-
fraction motion measurement. 
 
4.7  Optical methods 
Optical imaging may only provide information on the external anatomy, but may be 
completely non-invasive and requires zero dose. Its effective use requires knowledge 
of the relationship between the motion of the target and the external anatomy. Two 
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basic types of system exist: those that use infrared imaging of localised reflective, or 
active, markers to track motion, and those that use video camera data, which may be 
used to measure surface outline or to track. One of the first systems developed used a 
plastic block with infrared markers (Ford et al. 2002a). Other systems use a set of 
markers (Soete et al. 2002, Marmulla et al. 2004) either attached to the patient’s skin 
or to a holder. These systems are also often used to register the position in the 
treatment room of the ultrasound systems discussed above. Video systems to track 
motion have used correlation measurement (Yan et al. 2002). Video outlining has 
been achieved using stereoscopic measurement of the contour of the room laser on the 
patient surface (Wilks and Bliss 2002), feature-based CT outline matching (Ploeger et 
al. 2003) and stereoscopic imaging of a speckle pattern projected onto the patient 
surface (Moore et al. 2003, Schöffel et al. 2007). The intrinsic accuracy of such 
systems has been shown to be high, with the ability to measure patient shifts of under 
1 mm. 
 
Gierga et al. (2005) evaluated the relationship between internal and external anatomy 
for liver patients, measured with fluoroscopy of implanted fiducial clips and 
radioopaque markers placed on the skin. Results showed the variation in tumour 
position for a given external marker position ranged between 2 and 9 mm, illustrating 
the importance of using information on internal anatomy. A solution to this problem is 
to use external anatomy but to update its relationship with internal anatomy 
periodically using radiographic images (Kanoulas et al. 2007). 
 
5. Conclusions 
This review has focused on the use of anatomical imaging in radiotherapy, with the 
accompanying article discusses biological imaging. The combination of information 
from these complementary imaging modalities is expected to have great synergistic 
benefit for cancer treatment. This is of particular relevance for target definition, which 
remains the most important source of error in radiotherapy. Anatomical imaging with 
CT and MRI yield different gross tumour volumes. Functional imaging with 
modalities such as PET will generally reveal a different volume still. Thus a decision 
has to be made how to combine such information. In the absence of good 
histopathological information, or a proven quantitative biological imaging marker for 
clonogenic cell density, there is likely to be no gold standard imaging method for a 
particular treatment case. 
 
Anatomical imaging techniques have an important role to play in image guided 
treatment verification. At present several methods are being used as described in the 
literature. A recent AAPM meeting (Pouliot et al. 2007) included a debate on the 
future of IGRT verification, discussing five approaches and finishing with a vote as to 
which method was going to be the ‘winner’. Debates such as this are important, as 
they encourage discussion of the approaches to IGRT, but it is likely that the optimum 
solutions will be based on a combination of these approaches as each of the methods 
have advantages and disadvantages as presented in table 1. Another current area of 
discussion in IGRT verification is the dose associated with procedures such as 
kilovoltage conebeam CT. This was also debated at a recent conference (Van Herk 
and Lomax 2007). Kilovoltage CT is often considered to provide the best imaging 
information for IGRT, but the dose remains an issue for many, because it potentially 
involves significant extra skin dose, due to the low x-ray energy used, and delivers a 
bath of low dose to tissue outside the target, which may entail the risk of cancer 
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induction. The consequences of this are disease site specific for several reasons. 
Firstly, the patient age, expected survival and quality of life and disease recurrence 
risk vary greatly with disease site and the judgement as to what extra imaging dose is 
acceptable has to consider these issues. In the case of disease sites where long term 
survival is expected to be good, an approach based on a combination of the zero extra 
dose methods and those that do require extra dose may be best. A risk adapted 
approach to verification is necessary in which a judgement is made as to the trade off 
between the risk of the extra dose and the risk of the level of inaccuracy without the 
use of that technique. This should include consideration of a multimodality approach 
to verification. A second site specific consideration is based on radiobiology. There is 
evidence that several common tumour types exhibit a low α/β ratio (Fowler et al. 
2001, Yarnold et al. 2005). A consequence of this is that hypofractionation may 
become a more attractive treatment approach. In this case the dose associated with an 
x-ray based scan becomes a smaller fraction of the total dose delivered in treatment, 
hence reducing the relative risk. 
 
The past decade has seen significant advances in medical imaging and in the way 
imaging is used in radiation therapy. More information than ever may be obtained to 
assist in designing a patient’s treatment, delivering and monitoring the accuracy of 
that treatment and to following its progress and quantify effectiveness. Debate still 
exists as to what information is sufficient and how best to harvest that information. 
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Table Caption 
 
Table 1: Summary of properties of imaging methods used for image guided 
radiotherapy. MV denotes megavoltage and kV kilovoltage. 
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Figure Captions 
 
Figure 1: Isosurface rendering of a spherical object, CT scanned while periodically 
moving on a sliding table. Top row: different artefacts obtained by standard axial CT 
scanning starting at different motion phases. Bottom row: left shows a CT scan of the 
static object. Other images show 3 positions of the sphere while moving as imaged 
with 4DCT. Reproduced with kind permission from Rietzel et al. 2005b. 
 
Figure 2: Illustration of the planning target volume (PTV, left) and confidence-
limited planning target volume (cl-PTV, right) on the sagittal CT scan of a patient, 
and the corresponding treated volume (gray shaded area) on the beam’s eye view 
digitally reconstructed radiograph. Pink shows prostate, rectum yellow and bladder 
green. Reproduced with kind permission from Martinez et al. 2001. 
 
Figure 3: Illustration of a perfusion study for head and neck cancer. a) shows a 
transaxial CT slice with various regions of interest (ROIs) marked. b) shows 
measured CT number as a function of time for a selection of the ROIs. The ROIs are: 
arterial input (1), tumour (2, 7 and 8) sternocleidomastoid muscles (SCM) (3 and 6) 
and trapezius muscles (TZ) (4 and 5). Reproduced with kind permission from 
Castellano 2006. 
 
Figure 4: CT image of a prostate with an implanted fiducial marker showing typical 
metal artefacts (A). B) and C) show the results of two methods of artefact correction. 
Reproduced with kind permission from Bal and Spies 2006. 
 
Figure 5: CT slice through a prostate (a) and the corresponding MR scan (b). 
Reproduced with kind permission from Khoo et al. 2006. 
 
Figure 6: Gross tumour volume delineations of nine observers on transaxial CT (left) 
and transaxial MRI (right). Reproduced with kind permission from Weltens et al. 
2001. 
 
Figure 7: Linearity test phantom (left) and an uncorrected coronal MRI scan acquired 
from this phantom (right). The spots within the image arise from a regular lattice of 
water-filled marker tubes. Image distortion is evident from the irregular positioning of 
the spots and warping out of the plane of the image is seen in the appearance and 
disappearance of the straight marker tubes lying in the imaging plane. This image was 
acquired at the periphery of the imaging volume and hence distortion is particularly 
severe in this case. Reproduced with kind permission from Tanner et al. 2000. 
 
Figure 8: Fluoroscopic real-time tumour tracking system, showing three of the four 
fluoroscopy systems. Reproduced with kind permission from Shirato et al. 2000a. 
 
Figure 9: Sagittal conebeam CT slice through a prostate patient. The image shows 
various soft tissue features: bladder (B), prostate (P), seminar vesicles (SV), rectum 
(R) and sigmoid colon (S). Reproduced with kind permission from Létourneau et al. 
2005. 
 
 
